Product
AdCLD-CoV19-1
4 clinical trials
2 indications
Indication
COVID-19Indication
VaccinesClinical trial
A Dose Escalation, Multicenter, Open, Phase I Study to Assess the Safety and Immunogenicity of AdCLD-CoV19-1, a COVID-19 Preventive Vaccine in Healthy Volunteers.Status: Completed, Estimated PCD: 2022-12-02
Clinical trial
A Phase I/II (Single Center, Open, Phase I and Multicenter, Double-Blinded, Randomized, Placebo-Controlled, Phase II) Trial to Evaluate the Safety and Immunogenicity of the AdCLD-CoV19-1 OMI Administered as a Booster to Healthy Adults Aged 19 Years Old and AboveStatus: Active (not recruiting), Estimated PCD: 2023-12-01
Clinical trial
A Phase III Multinational, Multicenter, Observer-Blinded, Randomized, Active-Controlled Trial to Evaluate the Immunogenicity and Safety of the Preventive COVID-19 Vaccine AdCLD-CoV19-1 OMI Administered as a Booster to Adults Aged 19 Years Old and AboveStatus: Not yet recruiting, Estimated PCD: 2024-05-01
Clinical trial
A Phase IIb, Multicenter, Observer-Blinded, Randomized, Placebo-Controlled Trial to Evaluate the Immunogenicity and Safety of the AdCLD-CoV19-1 in Healthy Adults Aged 19 Years Old and AboveStatus: Terminated, Estimated PCD: 2022-11-08